Valuation: Stryker Corporation

Market Cap 126B 111B 102B 94.21B 179B 12,058B 182B 1,219B 479B 5,940B 475B 464B 20,420B P/E 2026 *
25.9x
P/E 2027 * 22.7x
Enterprise Value 135B 118B 109B 101B 191B 12,900B 194B 1,304B 512B 6,355B 508B 497B 21,846B EV / Sales 2026 *
4.96x
EV / Sales 2027 * 4.46x
Free-Float
94.62%
Yield 2026 *
1.09%
Yield 2027 * 1.17%
1 day+0.83%
1 week+1.70%
Current month+5.31%
1 month+5.86%
3 months-2.42%
6 months-8.17%
Current year-6.51%
1 week 316
Extreme 316
337.35
1 month 295
Extreme 295
340
Current year 281.04
Extreme 281.04
389.55
1 year 281.04
Extreme 281.04
405.83
3 years 250.79
Extreme 250.79
406.7
5 years 191.18
Extreme 191.18
406.7
10 years 127.68
Extreme 127.6758
406.7
Manager TitleAgeSince
Chief Executive Officer 60 30/09/2012
Director of Finance/CFO 50 31/03/2025
President 49 31/12/2025
Director TitleAgeSince
Director/Board Member 82 31/12/1973
Director/Board Member 71 31/12/1983
Chairman 60 21/07/2014
Change 5-day change 1-year change 3-year change Capi.($)
+0.34%+1.70% - - 126B
+1.27%+1.63%+3.17%-1.24% 12.9B
+0.13%+3.50%+47.72%+114.84% 8.97B
-2.84%-5.15%-50.08%-72.78% 3.98B
+1.52%+0.15%+22.38%+47.77% 2.7B
-5.07%-12.37%-19.07%-27.93% 1.74B
-1.19%-5.02%-7.21%-24.81% 1.61B
-1.44%+3.11%-60.86%-84.24% 1.49B
+3.90%+3.71%-15.96%-58.97% 1.48B
Average -0.25%+2.67%-9.99%-13.42% 4.36B
Weighted average by Cap. +0.70%+1.93%+4.90%+15.82%

Financials

2026 *2027 *
Net sales 27.27B 23.85B 22B 20.32B 38.55B 2,601B 39.2B 263B 103B 1,281B 102B 100B 4,404B 29.59B 25.88B 23.87B 22.05B 41.83B 2,822B 42.54B 285B 112B 1,390B 111B 109B 4,779B
Net income 4.84B 4.24B 3.91B 3.61B 6.85B 462B 6.97B 46.7B 18.34B 228B 18.19B 17.8B 783B 5.54B 4.85B 4.47B 4.13B 7.84B 529B 7.97B 53.44B 20.99B 260B 20.82B 20.36B 895B
Net Debt 8.83B 7.72B 7.12B 6.58B 12.48B 842B 12.69B 85.09B 33.42B 415B 33.14B 32.42B 1,426B 5.47B 4.78B 4.41B 4.07B 7.73B 521B 7.86B 52.7B 20.69B 257B 20.53B 20.08B 883B
Logo Stryker Corporation
Stryker Corporation is one of the world's leaders in designing, manufacturing and marketing medical equipment and devices in the fields of medical surgery, neurotechnology and orthopaedics. Net sales break down by family of products as follows: - surgical equipment and neurotechnology products (62.3%): electric motorized surgical instruments, surgical navigation systems, endoscopy equipment, digital imaging systems, neurosurgery equipment, neurovascular devices, etc. The group also offers hospital beds, gurneys, stretchers, and emergency room equipment; - orthopedic implants (37.7%): joint prostheses, traumatology implants, micro-implants, orthopedic cement, orthobiology products, etc. The group also provides spinal implants. At the end of 2025, the group had 55 manufacturing sites worldwide. Net sales are distributed geographically as follows: the United States (75.7%), Europe/Middle East/Africa (12.7%), Asia/Pacific (8.6%) and other (3%).
Employees
56,000
Date Price Change Volume
10/07/26 US$330.43 +0.72% 471
09/07/26 US$328.07 -0.08% 743
08/07/26 US$328.34 +0.45% 520
07/07/26 US$326.86 +0.17% 1,950
Trader
Investor
Global
Quality
ESG MSCI
AA
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
28
Last Close Price
329.78USD
Average target price
385.92USD
Spread / Average Target
+17.02%

Quarterly revenue - Rate of surprise